Bacterial Transmission In Utero and IBD Risk
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to IBD
Related studies linked through entity extraction aliases.
Identifying a Sleep Screener for Disease Relapse in Children With Inflammatory Bowel Disease
- Status
- UNKNOWN
- Phase
- N/A
Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects in Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical and Molecular Phenotyping in IBD
- Status
- COMPLETED
- Phase
- NA
Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)
- Status
- COMPLETED
- Phase
- NA
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
- Status
- COMPLETED
- Phase
- N/A
Intestinal Microbiome and Psychological Correlates in Irritable Bowel Syndrome and Inflammatory Bowel Disease
- Status
- COMPLETED
- Phase
- NA
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
- Status
- COMPLETED
- Phase
- N/A
IBD Cancer and Serious Infection in Europe
- Status
- COMPLETED
- Phase
- N/A
Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility Study
- Status
- COMPLETED
- Phase
- N/A
Capsule Endoscopy in Inflammatory Bowel Disease (IBD) in Children
- Status
- COMPLETED
- Phase
- NA
IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD.
- Status
- UNKNOWN
- Phase
- N/A
Anal Dysplasia in Patients With Inflammatory Bowel Disease
- Status
- COMPLETED
- Phase
- NA
Stavanger University Hospital Inflammatory Bowel Disease Trial
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
- Status
- COMPLETED
- Phase
- PHASE3